Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535 for the Treatment of Hypertension in Participants With Obesity or Overweight
NCT07528027Phase 3Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-7535 in hypertension (HTN), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
HRS-7535
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07528027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528027.